Evidence map›Paper›PMID 30836884›Full record

ArticleBiology letters2019

Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.

Lauri Mikonranta, Angus Buckling, Matti Jalasvuori, Ben Raymond

Open access · bronzeAbstract read
In one paragraph

Article in Biology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Aerobic and facultative anaerobicFrontiers in immunology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lauri Mikonranta1 School of Biosciences, University of Exeter , Penryn Campus, Penryn, Cornwall TR10 9FE , UK.
Angus Buckling1 School of Biosciences, University of Exeter , Penryn Campus, Penryn, Cornwall TR10 9FE , UK.
Matti Jalasvuori3 Department of Biological and Environmental Science, Nanoscience Center, University of Jyväskylä , PL 35, 40014 Jyväskylä , Finland.
Ben Raymond1 School of Biosciences, University of Exeter , Penryn Campus, Penryn, Cornwall TR10 9FE , UK.
University of Exeter · GBUniversity of Jyväskylä · FI

Funding

Medical Research Council MR/N013824/1
6 · The paper itself

Abstract

Phage therapy is attracting growing interest among clinicians as antibiotic resistance continues becoming harder to control. However, clinical trials and animal model studies on bacteriophage treatment are still scarce and results on the efficacy vary. Recent research suggests that using traditional antimicrobials in concert with phage could have desirable synergistic effects that hinder the evolution of resistance. Here, we present a novel insect gut model to study phage-antibiotic interaction in a system where antibiotic resistance initially exists in very low frequency and phage specifically targets the resistance bearing cells. We demonstrate that while phage therapy could not reduce the frequency of target bacteria in the population during positive selection by antibiotics, it alleviated the antibiotic induced blooming by lowering the overall load of resistant cells. The highly structured gut environment had pharmacokinetic effects on both phage and antibiotic dynamics compared with in vitro: antibiotics did not reduce the overall amount of bacteria, demonstrating a simple turnover of gut microbiota from non-resistant to resistant population with little cost. The results imply moderate potential for using phage as an aid to target antibiotic resistant gut infections, and question the usefulness of in vitro inferences.

Indexed as

BacteriophagesPhage TherapyAnimalsAnti-Bacterial AgentsBacteriaInsectaAnti-Bacterial Agentsantibiotic resistancebacteriophageEnterobacter cloacaegut infectioninsect modelphage therapy

Identifiers

PMID30836884
PMCPMC6451383
OpenAlexW2904321141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.